Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Apremilast for Chronic Plaque Psoriasis (CPP) Patients Who Have Failed One Course of Biologic Therapy

This study has been withdrawn prior to enrollment.
(Contract never executed; withdrawn by sponsor)
Sponsor:
Information provided by:
Duke University
ClinicalTrials.gov Identifier:
NCT01200264
First received: September 10, 2010
Last updated: July 14, 2014
Last verified: September 2010
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: September 2012
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)